Status:

NOT_YET_RECRUITING

The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study

Lead Sponsor:

Assiut University

Conditions:

Maspin in Colorectal Carcinoma

Eligibility:

All Genders

18-90 years

Brief Summary

Colorectal carcinoma (CRC) is a common cancer that arises from genetic and epigenetic changes in colon stem cells. The protein maspin acts as a tumor suppressor, influencing cell adhesion, motility, a...

Detailed Description

Colorectal carcinoma (CRC) ranks as the third most common cancer worldwide, significantly contributing to cancer-related deaths and increasingly affecting younger populations .CRC develops when stem c...

Eligibility Criteria

Inclusion

  • all patients with different stages of colorectal carcinoma with available paraffin blocks and clinical data .

Exclusion

  • all cases not fulfill the inclusion criteria .

Key Trial Info

Start Date :

August 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

January 1 2029

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06915350

Start Date

August 1 2025

End Date

January 1 2029

Last Update

April 8 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.